NCT06454448
- Conditions
- Adebrelimab (SHR-1316), Decitabine, Digestive System Diseases, +8 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
Clinical trial condition
Explore clinical trials studying Decitabine. Study availability and eligibility vary by location and protocol.
NCT06454448